Furthermore, the tests on combination with anticancer drugs that are ABCB1 or ABCG2 substrates, showed that peptide XH-14C potentiates the cytotoxicity of paclitaxel and doxorubicin in ABCB1-overexpressing cancer cells. This evidence concerns the gene ABCG2 and cancer.